L1: hematopoeisis
L2: iron metabolism
	- iron food

L3: hemolytic anemias
	- rituximab: TTP, antibody-mediated hemolytic anemia (AMHA) (cold + warm)
	- plasmapheresis / plasma exchange: TTP
	- steroids: TTP, warm AMHA
	- pegcetacoplan - C3 inhibitor: paroxysmal nocturnal hemogolbinuria (PNH)
	- eculizumab - C5 inhibitor: PNH

L4: normal hemostasis
L5: megaloblastic anemi
	- folate
	- cobalamin

L6: prothrombotic disorders
	- cryoprecipite - fibrinogen: DIC
	- fresh frozen plasma - factors: DIC
	- platelets: DIC
	- heparin: rarely DIC
	- caplicizumab - binds VWF
	- vincristine: TTP

L7: thalassemias and hemoglobinopathies
	- iron chelation: β thalassemia, 
	- transfusions: β thalassemia
	- allogeneic stem cell transplant: β thalassemia
	- splenectomy: sickle cell disease
	- hydroxyurea: sickle cell disease

L8: bleeding disorders
	- prophylactic recombinant factor replacement: hemophilia
	- emicizumab: hemophilia
	- aminocaproic acid: VWD
	- tranexamic acid: VWD
	- desmopressin (ddAVP): VWD, uremic platelet dysfunction
	- steroids: ITP
	- IV IG: ITP
	- IV anti-D WinRho: ITP
	- splenectomy: ITP
	- rituximab: ITP
	- romiplostim / eltrombopag - thrombopoeitin mimetics: ITP
	- cryoprecipite: VWD, DIC
	- heparin: DIC

L9:

L10:
